首页 > 最新文献

Journal of epidemiology and biostatistics最新文献

英文 中文
Ethics in epidemiology: common misconceptions, paradoxes and unresolved questions. 流行病学中的伦理学:常见的误解、悖论和未解决的问题。
Pub Date : 2009-10-01 DOI: 10.2105/9780875531939CH02
S. Coughlin
{"title":"Ethics in epidemiology: common misconceptions, paradoxes and unresolved questions.","authors":"S. Coughlin","doi":"10.2105/9780875531939CH02","DOIUrl":"https://doi.org/10.2105/9780875531939CH02","url":null,"abstract":"","PeriodicalId":80024,"journal":{"name":"Journal of epidemiology and biostatistics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67593081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol intake and high density lipoprotein-cholesterol: comparison of food frequency questionnaire and diet record in a general population sample. 酒精摄入与高密度脂蛋白-胆固醇:普通人群食物频率问卷与饮食记录的比较
Pub Date : 2001-12-27 DOI: 10.1080/135952201317080409
E. Müller, T. Stürmer, H. Brenner
BACKGROUNDModerate alcohol consumption is known to affect several cardiovascular risk factors, including high density lipoprotein-cholesterol (HDL-C). Accurate measurement of alcohol intake in epidemiological studies is crucial for valid estimation of alcohol-related effects.METHODSWe compared two widely used alcohol-intake assessment methods, a food frequency questionnaire (FFQ) and a 7-day diet record (DR) regarding the association between alcohol intake and HDL-C in the general population.RESULTSIn a representative sample (842 men, 1103 women) of the population of former West Germany (VERA study), 75.6% of the participants reported drinking alcoholic beverages in the FFQ, whereas the percentage was 84.9% according to the DR. The median daily alcohol intake of consumers was 10.3 and 12.1 g, as assessed by the FFQ and the DR, respectively. There was moderate agreement between reported consumption levels ranked by quintiles according to FFQ and DR (kappa = 0.49). With both approaches alcohol intake showed a strong positive association with HDL-C in linear regression models. The estimated increases in HDL-C (mg dL(-1)) per gram alcohol per day from the FFQ and DR were 0.15 [95% confidence interval (CI): 0.12-0.18] and 0.14 (95% CI: 0.11-0.17), respectively. When participants with different classification of the amount of alcohol consumed by FFQ and DR were excluded from the analysis, the association between alcohol intake and HDL-C was more pronounced.DISCUSSIONOur analyses suggest that both FFQ and DR lead to similar results regarding the alcohol-HDL-C association in the general population, despite major differences in the recorded prevalence of drinking and amount of alcohol consumed. Both methods may tend to under-estimate the true alcohol-HDL-C association.
背景:已知适度饮酒会影响几种心血管危险因素,包括高密度脂蛋白-胆固醇(HDL-C)。流行病学研究中准确测量酒精摄入量对于有效估计酒精相关影响至关重要。方法比较两种广泛使用的酒精摄入评估方法,即食物频率问卷(FFQ)和7天饮食记录(DR),以了解普通人群中酒精摄入与HDL-C之间的关系。结果在前西德人口的代表性样本(842名男性,1103名女性)(VERA研究)中,75.6%的参与者报告在FFQ中饮用酒精饮料,而根据DR,这一比例为84.9%。根据FFQ和DR评估,消费者的平均每日酒精摄入量分别为10.3 g和12.1 g。根据FFQ和DR按五分位数排列的报告消费水平之间存在适度的一致性(kappa = 0.49)。在线性回归模型中,两种方法均显示酒精摄入量与HDL-C呈正相关。据估计,FFQ和DR每天每克酒精增加的HDL-C (mg dL(-1))分别为0.15[95%可信区间(CI): 0.12-0.18]和0.14 (95% CI: 0.11-0.17)。当FFQ和DR饮酒量分类不同的参与者被排除在分析之外时,酒精摄入量与HDL-C之间的关联更加明显。讨论:我们的分析表明,尽管记录的饮酒流行程度和饮酒量存在重大差异,但在普通人群中,FFQ和DR在酒精- hdl - c相关性方面得出的结果相似。这两种方法都可能倾向于低估酒精与hdl - c之间的真正联系。
{"title":"Alcohol intake and high density lipoprotein-cholesterol: comparison of food frequency questionnaire and diet record in a general population sample.","authors":"E. Müller, T. Stürmer, H. Brenner","doi":"10.1080/135952201317080409","DOIUrl":"https://doi.org/10.1080/135952201317080409","url":null,"abstract":"BACKGROUND\u0000Moderate alcohol consumption is known to affect several cardiovascular risk factors, including high density lipoprotein-cholesterol (HDL-C). Accurate measurement of alcohol intake in epidemiological studies is crucial for valid estimation of alcohol-related effects.\u0000\u0000\u0000METHODS\u0000We compared two widely used alcohol-intake assessment methods, a food frequency questionnaire (FFQ) and a 7-day diet record (DR) regarding the association between alcohol intake and HDL-C in the general population.\u0000\u0000\u0000RESULTS\u0000In a representative sample (842 men, 1103 women) of the population of former West Germany (VERA study), 75.6% of the participants reported drinking alcoholic beverages in the FFQ, whereas the percentage was 84.9% according to the DR. The median daily alcohol intake of consumers was 10.3 and 12.1 g, as assessed by the FFQ and the DR, respectively. There was moderate agreement between reported consumption levels ranked by quintiles according to FFQ and DR (kappa = 0.49). With both approaches alcohol intake showed a strong positive association with HDL-C in linear regression models. The estimated increases in HDL-C (mg dL(-1)) per gram alcohol per day from the FFQ and DR were 0.15 [95% confidence interval (CI): 0.12-0.18] and 0.14 (95% CI: 0.11-0.17), respectively. When participants with different classification of the amount of alcohol consumed by FFQ and DR were excluded from the analysis, the association between alcohol intake and HDL-C was more pronounced.\u0000\u0000\u0000DISCUSSION\u0000Our analyses suggest that both FFQ and DR lead to similar results regarding the alcohol-HDL-C association in the general population, despite major differences in the recorded prevalence of drinking and amount of alcohol consumed. Both methods may tend to under-estimate the true alcohol-HDL-C association.","PeriodicalId":80024,"journal":{"name":"Journal of epidemiology and biostatistics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59835071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer by J Mackay... J Mackay为50岁以下有乳腺癌家族史的女性制定的乳房x光检查服务评估方案…
Pub Date : 2001-09-01 DOI: 10.1080/135952201753336852
L. Bisanti, A. Russo
{"title":"Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer by J Mackay...","authors":"L. Bisanti, A. Russo","doi":"10.1080/135952201753336852","DOIUrl":"https://doi.org/10.1080/135952201753336852","url":null,"abstract":"","PeriodicalId":80024,"journal":{"name":"Journal of epidemiology and biostatistics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59836254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer by J Mackay... J Mackay为50岁以下有乳腺癌家族史的女性制定的乳房x光检查服务评估方案…
Pub Date : 2001-09-01 DOI: 10.1080/135952201753337022
J. Benichou
{"title":"Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer by J Mackay...","authors":"J. Benichou","doi":"10.1080/135952201753337022","DOIUrl":"https://doi.org/10.1080/135952201753337022","url":null,"abstract":"","PeriodicalId":80024,"journal":{"name":"Journal of epidemiology and biostatistics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59837011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Projecting severe sequelae of injection-related hepatitis C virus epidemic in UK by SM Bird, DJ Goldberg and SJ Hutchinson SM Bird, DJ Goldberg和SJ Hutchinson预测注射相关丙型肝炎病毒流行在英国的严重后遗症
Pub Date : 2001-05-01 DOI: 10.1080/135952201317080689
M. Law, G. Dore, J. Kaldor
{"title":"Projecting severe sequelae of injection-related hepatitis C virus epidemic in UK by SM Bird, DJ Goldberg and SJ Hutchinson","authors":"M. Law, G. Dore, J. Kaldor","doi":"10.1080/135952201317080689","DOIUrl":"https://doi.org/10.1080/135952201317080689","url":null,"abstract":"","PeriodicalId":80024,"journal":{"name":"Journal of epidemiology and biostatistics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59835546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two cheers for P-values? by S Senn 为p值欢呼两声?作者:S·森
Pub Date : 2001-03-01 DOI: 10.1080/135952201753172962
A. Gould, C. Begg, Jam Mar
{"title":"Two cheers for P-values? by S Senn","authors":"A. Gould, C. Begg, Jam Mar","doi":"10.1080/135952201753172962","DOIUrl":"https://doi.org/10.1080/135952201753172962","url":null,"abstract":"","PeriodicalId":80024,"journal":{"name":"Journal of epidemiology and biostatistics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59835793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Using splines to analyse latency in the Colorado Plateau uranium miners cohort. 用样条分析科罗拉多高原铀矿工人队列的潜伏期。
Pub Date : 2001-01-01 DOI: 10.1080/135952201317225444
M. Hauptmann, K. Berhane, B. Langholz, J. Lubin
BACKGROUND Different approaches have been proposed to investigate latency in epidemiologic studies where detailed exposure histories are available. METHODS We demonstrate the application of a flexible, yet parsimonious, spline function model to investigate latency patterns for radon progeny exposure and lung cancer in the Colorado Plateau uranium miners cohort. The model extends a previously proposed bilinear model. RESULTS The excess relative risk (ERR) reached a maximum of 0.6 per 100 working level months, for exposures received 14 years previously. The ERR then declined, and was estimated to approach zero for exposures received 35 years and more in the past. The point-wise 95% confidence intervals supported ERRs > 0 for the period 9-32 years before the event. The estimated latency curve was homogeneous across categories of attained age, duration of exposure, rate of exposure, and smoking. CONCLUSIONS The proposed spline model is a flexible tool for latency analyses, and extends previously used methods.
背景:在有详细暴露史的流行病学研究中,已经提出了不同的方法来调查潜伏期。方法我们展示了一个灵活而简洁的样条函数模型的应用,以研究氡子代暴露和肺癌在科罗拉多高原铀矿工人队列中的潜伏期模式。该模型扩展了先前提出的双线性模型。结果14年前接触者的超相对危险度(ERR)最高为0.6 / 100个工作水平月。之后ERR下降,据估计,在过去35年及以上的暴露中ERR接近于零。逐点95%置信区间支持事件发生前9-32年的ERRs。估计的潜伏期曲线在达到年龄、暴露时间、暴露率和吸烟等类别中是均匀的。结论所提出的样条模型是一种灵活的延迟分析工具,并扩展了以前使用的方法。
{"title":"Using splines to analyse latency in the Colorado Plateau uranium miners cohort.","authors":"M. Hauptmann, K. Berhane, B. Langholz, J. Lubin","doi":"10.1080/135952201317225444","DOIUrl":"https://doi.org/10.1080/135952201317225444","url":null,"abstract":"BACKGROUND Different approaches have been proposed to investigate latency in epidemiologic studies where detailed exposure histories are available. METHODS We demonstrate the application of a flexible, yet parsimonious, spline function model to investigate latency patterns for radon progeny exposure and lung cancer in the Colorado Plateau uranium miners cohort. The model extends a previously proposed bilinear model. RESULTS The excess relative risk (ERR) reached a maximum of 0.6 per 100 working level months, for exposures received 14 years previously. The ERR then declined, and was estimated to approach zero for exposures received 35 years and more in the past. The point-wise 95% confidence intervals supported ERRs > 0 for the period 9-32 years before the event. The estimated latency curve was homogeneous across categories of attained age, duration of exposure, rate of exposure, and smoking. CONCLUSIONS The proposed spline model is a flexible tool for latency analyses, and extends previously used methods.","PeriodicalId":80024,"journal":{"name":"Journal of epidemiology and biostatistics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59835449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 40
Prevalence of urinary symptoms in urban Australian men aged 40-69. 澳大利亚40-69岁城市男性泌尿系统症状的患病率
Pub Date : 2001-01-01 DOI: 10.1080/135952201753172980
M. Mccredie, M. Staples, W. Johnson, D. English, G. Giles
BACKGROUND This study was devised to determine the prevalence of urinary symptoms among men living in the Australian cities of Melbourne, Sydney or Perth, and to identify factors associated with the presence of moderate-to-severe urinary symptoms. METHODS The study comprised a population-based sample of 1,216 men, aged 40-69 years, whose names were obtained through electoral rolls and who participated as controls in a case-control study of risk factors for prostate cancer. As part of a structured face-to-face interview, the men completed the International Prostate Symptom Score (IPSS). Men with moderate (IPSS = 8-19) or severe (IPSS > or = 20) urinary symptoms were compared with those with mild or no symptoms (IPSS < 8) using unconditional logistic regression. RESULTS The age-specific prevalence of moderate-to-severe urinary symptoms (IPSS > or = 8) in men aged 40-49, 50-59, 60-69 years was 16%, 23% and 28%, respectively. Compared with men with no or mild urinary symptoms (IPSS < 8), men with moderate-to-severe symptoms were more likely to report not currently living as married [odds ratio (OR) = 1.5; 95% confidence interval (CI) 1.1-2.0] and being circumcised (OR = 1.5; 95% Cl 1.2-2.0). The increased likelihood associated with drinking an average of > 60 g day(-1) of alcohol in the 2 years before interview was of marginal statistical significance (OR = 1.6; 1.0-2.6). There were no significant differences between men with IPSS > or = 8 and those with IPSS < 8 with respect to body mass index, education level, having had a vasectomy, or cigarette smoking. CONCLUSION Among Australian men, being circumcised, or not currently living as married, were associated with increased prevalence of urinary symptoms.
背景:本研究旨在确定生活在澳大利亚墨尔本、悉尼或珀斯的男性泌尿系统症状的患病率,并确定与中重度泌尿系统症状存在相关的因素。方法该研究包括以人群为基础的1,216名年龄在40-69岁之间的男性样本,他们的名字是通过选举名册获得的,并作为对照组参加了前列腺癌危险因素的病例对照研究。作为结构化面对面访谈的一部分,这些男性完成了国际前列腺症状评分(IPSS)。使用无条件logistic回归将中度(IPSS = 8-19)或重度(IPSS >或= 20)泌尿系统症状的男性与轻度或无症状(IPSS < 8)的男性进行比较。结果40-49岁、50-59岁、60-69岁男性中重度尿路症状(IPSS >或= 8)的年龄特异性患病率分别为16%、23%和28%。与没有或轻度泌尿系统症状(IPSS < 8)的男性相比,有中度至重度症状的男性更有可能报告目前没有结婚[优势比(or) = 1.5;95%置信区间(CI) 1.1-2.0]和行包皮环切术(OR = 1.5;95% Cl 1.2-2.0)。访谈前2年平均每天饮酒60克(-1)与增加的可能性有边际统计学意义(OR = 1.6;1.0 - -2.6)。IPSS患者>或= 8与IPSS < 8的男性在体重指数、教育水平、是否做过输精管切除术或吸烟方面没有显著差异。结论:在澳大利亚男性中,接受过包皮环切术或目前没有结婚的男性与泌尿系统症状的患病率增加有关。
{"title":"Prevalence of urinary symptoms in urban Australian men aged 40-69.","authors":"M. Mccredie, M. Staples, W. Johnson, D. English, G. Giles","doi":"10.1080/135952201753172980","DOIUrl":"https://doi.org/10.1080/135952201753172980","url":null,"abstract":"BACKGROUND This study was devised to determine the prevalence of urinary symptoms among men living in the Australian cities of Melbourne, Sydney or Perth, and to identify factors associated with the presence of moderate-to-severe urinary symptoms. METHODS The study comprised a population-based sample of 1,216 men, aged 40-69 years, whose names were obtained through electoral rolls and who participated as controls in a case-control study of risk factors for prostate cancer. As part of a structured face-to-face interview, the men completed the International Prostate Symptom Score (IPSS). Men with moderate (IPSS = 8-19) or severe (IPSS > or = 20) urinary symptoms were compared with those with mild or no symptoms (IPSS < 8) using unconditional logistic regression. RESULTS The age-specific prevalence of moderate-to-severe urinary symptoms (IPSS > or = 8) in men aged 40-49, 50-59, 60-69 years was 16%, 23% and 28%, respectively. Compared with men with no or mild urinary symptoms (IPSS < 8), men with moderate-to-severe symptoms were more likely to report not currently living as married [odds ratio (OR) = 1.5; 95% confidence interval (CI) 1.1-2.0] and being circumcised (OR = 1.5; 95% Cl 1.2-2.0). The increased likelihood associated with drinking an average of > 60 g day(-1) of alcohol in the 2 years before interview was of marginal statistical significance (OR = 1.6; 1.0-2.6). There were no significant differences between men with IPSS > or = 8 and those with IPSS < 8 with respect to body mass index, education level, having had a vasectomy, or cigarette smoking. CONCLUSION Among Australian men, being circumcised, or not currently living as married, were associated with increased prevalence of urinary symptoms.","PeriodicalId":80024,"journal":{"name":"Journal of epidemiology and biostatistics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59836278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data. 预测在英国注射相关丙型肝炎病毒流行的严重后遗症。第一部分:关键丙型肝炎和注射器数据。
Pub Date : 2001-01-01 DOI: 10.1080/135952201317080661
Sheila M. Bird, Goldberg Dj, Sharon J. Hutchinson
BACKGROUND Hepatitis C is transmitted by transfusion of unscreened blood, through injecting drugs, from mother-to-child and, on occasion, sexually. Transmission generally requires that the infector is hepatitis C virus (HCV) RNA positive, a 'carrier'. About three-quarters of injectors who are hepatitis C antibody positive are HCV-RNA positive and so infectious to others. Incubation periods from HCV infection to cirrhosis and hepatocellular carcinoma are even longer than from HIV infection to AIDS, being counted in decades; they depend on age, gender, alcohol consumption and co-infection with other viruses. We identify 25 data sources that are available, or required, for projecting the severe sequelae of the injection-related hepatitis C epidemic. DATA SOURCES Three data sources relate to hepatitis C diagnosis: register of confirmed HCV infections (with initial of first name + soundex of surname + date of birth + gender = master index, exposure category, year of starting to inject, and region); surveys of HCV test-uptake by injectors and others; documentation of pregnancy and its outcome in HCV-infected women (injectors and others). Four data sources relate to HCV prevalence and incidence among injectors and others: anonymous testing for HCV antibodies in blood or saliva (for sentinel groups ranging from new blood donors, pregnant women, patients awaiting kidney transplantation, non-injector prisoners, health-care workers, non-injector heterosexuals attending genitourinary medicine clinics; to injectors in the community, at drug treatment centres or in prison); historical data on HCV prevalence in injectors; HCV incidence studies in injectors; and uptake of harm reduction measures--frequency of sharing and methadone substitution--by injectors. Key reporting problems in HCV incidence studies, which inhibit checks on the convenient exponential assumption for time from start of injecting to hepatitis C infection, are discussed. Nine critical data sources are identified for monitoring the late sequelae of hepatitis C carriage, its investigation and treatment: linkage surveillance, for example by master index, to identify deaths, hospitalisations or cancer registrations among confirmed HCV infections; surveys of HCV status among patients who undergo liver biopsy, are newly diagnosed with cirrhosis or are newly diagnosed with liver cancer; surveys of liver-biopsy rate in HCV-infected injectors and others; uptake and outcome of interferon + ribavirin in the treatment of hepatitis C carriers; cohort studies of HCV progression; sample surveys of genotype in HCV-infected injectors, and others; acute hepatitis B infections and uptake of hepatitis B immunisation by injectors; liver transplantation in HCV-infected patients; and hepatitis C-status and other risk factors in deaths from cirrhosis or liver cancer, to determine whether they are HCV and injector-related. Finally, nine critical data sources are identified for quantitative understanding of the under
背景:丙型肝炎可通过未经筛查的血液输入、注射毒品、母婴传播,有时还可通过性行为传播。传播通常要求感染者是丙型肝炎病毒(HCV) RNA阳性,即“携带者”。在丙型肝炎抗体呈阳性的注射者中,约有四分之三是丙型肝炎病毒rna呈阳性,因此对他人具有传染性。从丙型肝炎病毒感染到肝硬化和肝细胞癌的潜伏期甚至比从艾滋病毒感染到艾滋病的潜伏期还要长,以几十年计算;它们取决于年龄、性别、饮酒和与其他病毒的合并感染。我们确定了25个可用的或需要的数据来源,用于预测与注射相关的丙型肝炎流行的严重后遗症。数据来源与丙型肝炎诊断相关的三个数据来源:HCV确诊感染登记(姓名首字母+姓氏音指数+出生日期+性别=主指数、暴露类别、开始注射年份和地区);对注射者和其他人员进行丙型肝炎病毒检测的调查;丙型肝炎病毒感染妇女(注射者和其他)妊娠及其结局的记录。有四个数据来源与注射者和其他人中丙型肝炎病毒的流行和发病率有关:血液或唾液中丙型肝炎病毒抗体的匿名检测(针对哨点群体,包括新献血者、孕妇、等待肾移植的患者、非注射囚犯、卫生保健工作者、在泌尿生殖医学诊所就诊的非注射异性恋者;社区、戒毒中心或监狱的注射者);注射者丙型肝炎病毒流行的历史数据;注射者丙型肝炎病毒发病率研究;以及注射者采取减少危害措施——共用和美沙酮替代的频率。讨论了丙型肝炎发病率研究中的关键报告问题,这些问题抑制了从开始注射到丙型肝炎感染时间的方便指数假设的检查。确定了9个关键数据来源,用于监测丙型肝炎携带者的晚期后遗症、调查和治疗:联系监测,例如通过总指数,以确定确诊丙型肝炎感染中的死亡、住院或癌症登记;在接受肝活检、新诊断为肝硬化或新诊断为肝癌的患者中进行HCV状态调查;丙型肝炎病毒感染注射人员及其他人群肝活检率调查;干扰素+利巴韦林治疗丙型肝炎携带者的摄取及疗效HCV进展的队列研究;丙型肝炎病毒感染注射者的基因型抽样调查等;急性乙型肝炎感染和注射者接种乙型肝炎疫苗;丙型肝炎患者肝移植;丙型肝炎状态和其他肝硬化或肝癌死亡的危险因素,以确定它们是否与丙型肝炎病毒和注射器有关。最后,确定了用于定量了解潜在注射者流行病的九个关键数据源:药物滥用数据库加上用于评估注射者人数的捕获-再捕获方法,按区域划分的药物相关死亡人数用于评估注射者人数;感染艾滋病毒的注射者人数;注射者的艾滋病毒进展;注射者过量服用和其他死因;关于注射者发病率历史的专家意见,加上注射者职业生涯开始和持续时间的年龄分布的调查信息;从丙型肝炎感染献血者中推断出的注射器发病率;当前喷射器的年龄分布和开始时的年龄分布,作为对随机模拟中关于喷射器发生率和注射历史“意外”的假设的检验;前注射者的死亡率;以及在过去5年,去年和目前,幸存的注射者与注射者的总体人口或其他调查比例,作为对模拟的检查。建议我们推荐一种通用的HCV诊断报告表,以改善对危险因素信息的确定,特别是开始注射的年份——这是流行病学上的一个关键日期。我们还建议对当前和以前的注射者进行HCV检测的最新调查,或进行分母研究,登记所有HCV受测者的总指数和危险因素信息。我们建议对注射者进行调查,询问在今年、去年和注射第一年的三个不同时期每4周共用针头的典型频率。我们还建议存放注射者的历史样本的地点进行回顾性和匿名的HCV抗体检测。我们建议立即关注前注射者或恢复注射者丙型肝炎携带者接受联合治疗和对联合治疗的反应。我们娱乐
{"title":"Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.","authors":"Sheila M. Bird, Goldberg Dj, Sharon J. Hutchinson","doi":"10.1080/135952201317080661","DOIUrl":"https://doi.org/10.1080/135952201317080661","url":null,"abstract":"BACKGROUND Hepatitis C is transmitted by transfusion of unscreened blood, through injecting drugs, from mother-to-child and, on occasion, sexually. Transmission generally requires that the infector is hepatitis C virus (HCV) RNA positive, a 'carrier'. About three-quarters of injectors who are hepatitis C antibody positive are HCV-RNA positive and so infectious to others. Incubation periods from HCV infection to cirrhosis and hepatocellular carcinoma are even longer than from HIV infection to AIDS, being counted in decades; they depend on age, gender, alcohol consumption and co-infection with other viruses. We identify 25 data sources that are available, or required, for projecting the severe sequelae of the injection-related hepatitis C epidemic. DATA SOURCES Three data sources relate to hepatitis C diagnosis: register of confirmed HCV infections (with initial of first name + soundex of surname + date of birth + gender = master index, exposure category, year of starting to inject, and region); surveys of HCV test-uptake by injectors and others; documentation of pregnancy and its outcome in HCV-infected women (injectors and others). Four data sources relate to HCV prevalence and incidence among injectors and others: anonymous testing for HCV antibodies in blood or saliva (for sentinel groups ranging from new blood donors, pregnant women, patients awaiting kidney transplantation, non-injector prisoners, health-care workers, non-injector heterosexuals attending genitourinary medicine clinics; to injectors in the community, at drug treatment centres or in prison); historical data on HCV prevalence in injectors; HCV incidence studies in injectors; and uptake of harm reduction measures--frequency of sharing and methadone substitution--by injectors. Key reporting problems in HCV incidence studies, which inhibit checks on the convenient exponential assumption for time from start of injecting to hepatitis C infection, are discussed. Nine critical data sources are identified for monitoring the late sequelae of hepatitis C carriage, its investigation and treatment: linkage surveillance, for example by master index, to identify deaths, hospitalisations or cancer registrations among confirmed HCV infections; surveys of HCV status among patients who undergo liver biopsy, are newly diagnosed with cirrhosis or are newly diagnosed with liver cancer; surveys of liver-biopsy rate in HCV-infected injectors and others; uptake and outcome of interferon + ribavirin in the treatment of hepatitis C carriers; cohort studies of HCV progression; sample surveys of genotype in HCV-infected injectors, and others; acute hepatitis B infections and uptake of hepatitis B immunisation by injectors; liver transplantation in HCV-infected patients; and hepatitis C-status and other risk factors in deaths from cirrhosis or liver cancer, to determine whether they are HCV and injector-related. Finally, nine critical data sources are identified for quantitative understanding of the under","PeriodicalId":80024,"journal":{"name":"Journal of epidemiology and biostatistics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59835173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
Use of longitudinal data analysis in the determination of a global score for total hip replacement indication in osteoarthritis patients. 利用纵向数据分析确定骨关节炎患者全髋关节置换术指征的总体评分。
Pub Date : 2001-01-01 DOI: 10.1080/135952201317225471
J-P Nakache, A. Guéguen, Jf Maillefert, M. Dougados
BACKGROUND A composite index would help in medical practice for considering total hip replacement (THR) in hip osteoarthritis. In association with other parameters, such as age or general status, this index could serve to objectively determine the time to THR surgery, and might be used as an outcome measure in therapeutic trials. The objective of this study was to propose such an index, taking into account symptomatic, structural and therapeutic variables, and impact on lifestyle. METHODS A curve-fitting procedure and a marginal model were used to highlight the average change in the variables over time. A discrete Cox model, with time-dependent covariates. was then performed to study the association between the variables and hip surgery, leading to the construction of a composite index. RESULTS The smoothing and fitting analysis suggested takes into account not only the variables, but also the changes in their values during the preceding year, when studying the association between variables and hip surgery. Five covariates were retained in the Cox model, among them only one concerns the changes during the preceding year, showing that the values of the covariates are more important that their changes during the preceding year for THR indication. The coefficients of the model were transformed into new coefficients, so that their sum provided a severity score with individual values 0-100. DISCUSSION Based on the values of reliable variables recorded during the four last visits, this score can be regarded as a valid index able to objectively help with THR indications. This score might also be used as an outcome measure in therapeutic trials.
背景:综合指数有助于临床实践中考虑全髋关节置换术治疗髋关节骨性关节炎。与其他参数(如年龄或一般状态)相结合,该指标可以客观地确定THR手术的时间,并可作为治疗试验的结果衡量标准。本研究的目的是提出这样一个指数,考虑到症状,结构和治疗变量,以及对生活方式的影响。方法采用曲线拟合程序和边际模型来突出变量随时间的平均变化。具有时变协变量的离散Cox模型。然后进行研究变量与髋关节手术之间的关系,从而构建一个综合指数。结果平滑和拟合分析表明,在研究变量与髋关节手术之间的关系时,不仅考虑了变量,而且考虑了变量值在前一年的变化。Cox模型中保留了5个协变量,其中只有1个协变量与前一年的变化有关,表明协变量的值比其前一年的变化对THR指示更重要。将模型的系数转换为新系数,使它们的总和提供单个值为0-100的严重性评分。基于最后四次就诊记录的可靠变量值,该评分可视为一种有效的指标,能够客观地帮助确定THR指征。该评分也可作为治疗试验的结果衡量标准。
{"title":"Use of longitudinal data analysis in the determination of a global score for total hip replacement indication in osteoarthritis patients.","authors":"J-P Nakache, A. Guéguen, Jf Maillefert, M. Dougados","doi":"10.1080/135952201317225471","DOIUrl":"https://doi.org/10.1080/135952201317225471","url":null,"abstract":"BACKGROUND A composite index would help in medical practice for considering total hip replacement (THR) in hip osteoarthritis. In association with other parameters, such as age or general status, this index could serve to objectively determine the time to THR surgery, and might be used as an outcome measure in therapeutic trials. The objective of this study was to propose such an index, taking into account symptomatic, structural and therapeutic variables, and impact on lifestyle. METHODS A curve-fitting procedure and a marginal model were used to highlight the average change in the variables over time. A discrete Cox model, with time-dependent covariates. was then performed to study the association between the variables and hip surgery, leading to the construction of a composite index. RESULTS The smoothing and fitting analysis suggested takes into account not only the variables, but also the changes in their values during the preceding year, when studying the association between variables and hip surgery. Five covariates were retained in the Cox model, among them only one concerns the changes during the preceding year, showing that the values of the covariates are more important that their changes during the preceding year for THR indication. The coefficients of the model were transformed into new coefficients, so that their sum provided a severity score with individual values 0-100. DISCUSSION Based on the values of reliable variables recorded during the four last visits, this score can be regarded as a valid index able to objectively help with THR indications. This score might also be used as an outcome measure in therapeutic trials.","PeriodicalId":80024,"journal":{"name":"Journal of epidemiology and biostatistics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"59835715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Journal of epidemiology and biostatistics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1